Transcription factors modulate the telomerase activity in cancer cells: The hTR gene promoter is activated by NF-Y, Sp1, pRB and HIF1; it is suppressed by Sp3 and signaling pathways such as JNK that cause a switch from Sp1 to Sp3 promoter binding [39–41]. The gene discussed is SP3; the disease is cancer.